Teladoc Health Inc
$
68.55
0.02 (0.03%)
| Volume: | 593,514 | Avg Vol (1m): | 1,183,116 |
| Market Cap $: | 4.91 Bil | Enterprise Value $: | 4.88 Bil |
| P/E (TTM): | 0.00 | P/B: | 4.84 |
| Earnings Power Value | -6.79 |
| Net Current Asset Value | -0.13 |
| Tangible Book | 0.41 |
| Projected FCF | 0 |
| Median P/S Value | 58.41 |
| Graham Number | 0 |
| Peter Lynch Value | 0 |
| DCF (FCF Based) | 0 |
| DCF (Earnings Based) | 0 |
1Y (-%)
Manual of Stocks™ Web
Financial Strength : 6.2/10
GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| Current | vs industry | vs history | |
|---|---|---|---|
| Cash-to-Debt | 1.07 |
Cash-To-Debt range over the past 10 years
Min: 0.33, Med: 1.23, Max: 5.61
Current: 1.07
| |
| Equity-to-Asset | 0.65 |
Equity-to-Asset range over the past 10 years
Min: 0.39, Med: 0.67, Max: 0.83
Current: 0.65
| |
| Debt-to-Equity | 0.45 |
Debt-to-Equity range over the past 10 years
Min: 0.12, Med: 0.38, Max: 0.83
Current: 0.45
| |
| Debt-to-EBITDA | -14.31 |
Debt-to-EBITDA range over the past 10 years
Min: -14.31, Med: -1.49, Max: -0.53
Current: -14.31
| |
| Piotroski F-Score | 4 |
0
1
2
3
4
5
6
7
8
9
| |
| Altman Z-Score | 5.50 |
DISTRESS
GREY
SAFE
| |
| Beneish M-Score | -2.21 |
Not Manipulator
Manipulator
| |
| WACC vs ROIC % |
ROIC -7.89%
WACC 12.95%
| ||
Profitability & Growth : 5/10
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
| Current | vs industry | vs history | |
|---|---|---|---|
| Operating Margin % | -15.39 |
Operating Margin range over the past 10 years
Min: -71.38, Med: -31.92, Max: -15.39
Current: -15.39
| |
| Net Margin % | -22.63 |
Net Margin range over the past 10 years
Min: -74.98, Med: -42.46, Max: -22.63
Current: -22.63
| |
| ROE % | -12.04 |
ROE range over the past 10 years
Min: -55.68, Med: -43.16, Max: -12.04
Current: -12.04
| |
| ROA % | -7.79 |
ROA range over the past 10 years
Min: -36.08, Med: -24.91, Max: -7.79
Current: -7.79
| |
| ROC (Joel Greenblatt) % | -471.37 |
ROC (Joel Greenblatt) range over the past 10 years
Min: -2142.41, Med: -1159.63, Max: -471.37
Current: -471.37
| |
| 3-Year Total Revenue Growth Rate | 75.40 |
3-Year Revenue Growth Rate range over the past 10 years
Min: 17.8, Med: 38.7, Max: 59.2
Current: 17.8
| |
| 3-Year Total EBITDA Growth Rate | 15.50 |
3-Year EBITDA Growth Rate range over the past 10 years
Min: -82.3, Med: -19.3, Max: 43.3
Current: 43.3
| |
| 3-Year EPS w/o NRI Growth Rate | 20.40 |
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: -30.9, Max: 20.4
Current: 20.4
|
» TDOC's 30-Y Financials
Financials (Next Earnings Date: 2019-07-31)
Guru Trades Click for details
Guru Trades in
SEC Filings
Gurus Latest Trades with NYSE:TDOC
» Interactive Chart
Peter Lynch Chart
Business Description
| Industry | Application Software » Application Software   NAICS : 621999   SIC : 8011 |
| Compare | XTER:COP SZSE:300253 NAS:PINC NAS:OMCL NAS:INOV NAS:MDSO HKSE:02666 NAS:HQY NYSE:EVH SZSE:300451 NAS:QSII NAS:TRHC NAS:HSTM NAS:RCM TSE:3902 LSE:CRW LSE:EMIS ASX:PME XPAR:CGM SHSE:603990 |
| Traded in other countries | 4LL.Germany 0LDR.UK |
| Address | 2 Manhattanville Road, Suite 203, Purchase, NY, USA, 10577 |
| Teladoc Inc is a telehealth platform that delivers 24-hour, on-demand healthcare via mobile devices, the Internet, video, and phone. Its platform connects members with a network of physicians and behavioral health professionals. The firm receives the majority of its revenue on a per-member-per-month basis from subscription access fees. The remainder of revenue comes from visit fees. Teledoc partners with employers, health plans, and health systems to offer its solutions to their members. Teledoc's platform matches members to healthcare providers in real time and is customizable for members, clients, and providers. | |
Ratios
| Current | vs industry | vs history | |
|---|---|---|---|
| PB Ratio | 4.84 |
PB Ratio range over the past 10 years
Min: 2.29, Med: 4.11, Max: 7.13
Current: 4.84
| |
| PS Ratio | 10.24 |
PS Ratio range over the past 10 years
Min: 4.19, Med: 8.74, Max: 14.64
Current: 10.24
| |
| Price-to-Operating-Cash-Flow | 4570.00 |
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 3440, Med: 3945, Max: 4773.32
Current: 4570
| |
| EV-to-EBIT | -69.35 |
EV-to-EBIT range over the past 10 years
Min: -81.5, Med: -31.4, Max: -4.9
Current: -69.35
| |
| EV-to-EBITDA | -155.34 |
EV-to-EBITDA range over the past 10 years
Min: -162.25, Med: -38.85, Max: -5.4
Current: -155.34
| |
| EV-to-Revenue | 10.66 |
EV-to-Revenue range over the past 10 years
Min: 3.2, Med: 9, Max: 15.7
Current: 10.66
| |
| Current Ratio | 7.54 |
Current Ratio range over the past 10 years
Min: 1.15, Med: 5.28, Max: 23.21
Current: 7.54
| |
| Quick Ratio | 7.54 |
Quick Ratio range over the past 10 years
Min: 1.15, Med: 5.28, Max: 23.21
Current: 7.54
| |
| Days Sales Outstanding | 40.41 |
Days Sales Outstanding range over the past 10 years
Min: 38.05, Med: 45.13, Max: 57.35
Current: 40.41
| |
| Days Payable | 19.27 |
Days Payable range over the past 10 years
Min: 5.84, Med: 24.27, Max: 81.24
Current: 19.27
|
Dividend & Buy Back
| Current | vs industry | vs history | |
|---|---|---|---|
| 3-Year Share Buyback Rate | -19.60 |
3-Year Share Buyback Rate range over the past 10 years
Min: -19.8, Med: -19.6, Max: -18.7
Current: -19.6
|
Valuation & Return
| Current | vs industry | vs history | |
|---|---|---|---|
| Price-to-Tangible-Book | 167.20 |
Price-to-Tangible-Book range over the past 10 years
Min: 3.95, Med: 10.28, Max: 224.87
Current: 167.2
| |
| Price-to-Median-PS-Value | 1.17 |
Price-to-Median-PS-Value range over the past 10 years
Min: 0.47, Med: 0.96, Max: 1.68
Current: 1.17
| |
| Earnings Yield (Joel Greenblatt) % | -1.45 |
Earnings Yield (Greenblatt) range over the past 10 years
Min: -20.4, Med: -3.2, Max: -1.2
Current: -1.45
|
More Statistics
| Revenue (TTM) (Mil) $ | 456.84 |
| EPS (TTM) $ | -1.52 |
| Beta | 1.88 |
| Volatility % | 58.4 |
| 52-Week Range $ | 42.08 - 89.05 |
| Shares Outstanding (Mil) | 71.59 |
Analyst Estimate
Piotroski F-Score Details
| Piotroski F-Score | 4 |
| Positive ROA | N |
| Positive CFROA | Y |
| Higher ROA yoy | Y |
| CFROA > ROA | Y |
| Lower Leverage yoy | N |
| Higher Current Ratio yoy | Y |
| Less Shares Outstanding yoy | N |
| Higher Gross Margin yoy | N |
| Higher Asset Turnover yoy | N |